Prophylactic antibiotics do not decrease the incidence of wound infections after laparoscopic pyloromyotomy

Michael S Katz1, Marshall Z Schwartz, Matthew L Moront

  • 1Department of Pediatric Surgery, St. Christopher's Hospital for Children, Philadelphia, PA 19134, USA.

Abstract

Insights

Prophylactic antibiotics did not significantly reduce wound infections or complications in laparoscopic pyloromyotomy patients. This study suggests routine antibiotic use may not be necessary for this clean surgical procedure.

Area of Science:

  • Pediatric Surgery
  • Surgical Infection Prevention

Background:

  • Laparoscopic pyloromyotomy is generally classified as a clean surgical procedure.
  • Despite its classification, prophylactic antibiotics are frequently administered preoperatively by surgeons.

Purpose of the Study:

  • To assess the effect of prophylactic antibiotics on the incidence of wound infections following laparoscopic pyloromyotomy.
  • To determine if routine antibiotic prophylaxis impacts other wound complication rates in this patient population.

Main Methods:

  • Retrospective chart review of patients undergoing laparoscopic pyloromyotomy from August 2002 to December 2009.
  • Data collected included patient demographics, serum bicarbonate levels, and antibiotic administration status.
  • Wound infection and complication rates were compared between patients who received antibiotics and those who did not.

Main Results:

  • A total of 301 laparoscopic pylorotomies were analyzed, with 194 patients included in the follow-up study.
  • The wound infection rate was 2.7% in the antibiotic group (n=111) and 3.5% in the no-antibiotic group (n=84), with no statistically significant difference (P = .73).
  • Other wound complications occurred in 4.5% of the antibiotic group versus 8.3% of the no-antibiotic group (P = .27).

Conclusions:

  • Prophylactic antibiotic use does not significantly lower the risk of wound infection after laparoscopic pyloromyotomy.
  • The study indicates that routine preoperative antibiotics may not be beneficial in preventing wound complications for this procedure.

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...